The UCSF Endocrine Surgery and Oncology program delivers state-of-the-art care surgical care, complemented by a strong clinical research enterprise geared towards discovering effective therapies to treat thyroid and other endocrine cancers. This approach is particularly important for patients who have exhausted conventional therapies. Our lab research is focused on gaining a better understanding of thyroid cancer biology, developing and improving diagnostic and predictive tests, and finding novel and innovative treatments.
Featured Videos View All »
Video
Handling Hypothyroidism: Management Basics and Pearls
Get more comfortable assessing patients for this common disorder, determining whether treatment is appropriate and initiating levothyroxine therapy. Endocrinologist Chienying Liu, MD, illuminates such issues as when to treat subclinical hypothyroidism.
Video
Knotty Problems of the Neck: A Guide for Primary Care
Endocrine surgeon Wen T. Shen, MD, MA, offers guidance on everything from physical exams to presurgical workups, including key factors in risk assessment, when to order imaging (and what type), and how to pick up on hyperparathyroidism, ...
Video
Complex Drugs, Complex Patients: Navigating New Options for Diabetes Management
Robert J. Rushakoff, MD, helps providers get up to speed on the latest drugs, explaining benefits, crucial caveats, and factors ranging from expense to nonadherence.
Video
Accidental Adrenal Findings: How to Identify the Serious “Incidentaloma”
In this guide to working up adrenal masses, endocrinologist Chienying Liu, MD, clears away the confusion on screening and interpretation of results. She provides usable flowcharts and tables showing appropriate tests to order as well as ...
Articles & Documents View All »
News
Autoantibody for Acquired Lipodystrophy Identified, Bringing Hope for Therapeutics
UCSF investigators have found an autoantibody biomarker for acquired lipodystrophy, paving the way for novel treatment options for this complex condition, which causes adipose tissue loss and metabolic complications.
News
New Research Linking Type 1 Diabetes to Genetic Mutations May Lead to Precision Medicine
UCSF researchers have discovered specific genetic mutations that can cause type 1 diabetes. This groundbreaking work could result in effective precision treatments for patients.
News
UCSF Case Study: Same-Day Discharge After Pheochromocytoma Removal
San Francisco endocrine surgeon Sanziana Roman, MD, performed a posterior retroperitoneoscopic adrenalectomy (PRA) to remove a pheochromocytoma. This approach enabled the patient to be discharged home within hours of surgery and avoid ...
News
Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control ...
The UCSF Endocrine Surgery and Oncology program delivers state-of-the-art care surgical care, complemented by a strong clinical research enterprise geared towards discovering effective therapies to treat thyroid and other endocrine cancers. This approach is particularly important for patients who have exhausted conventional therapies. Our lab research is focused on gaining a better understanding of thyroid cancer biology, developing and improving diagnostic and predictive tests, and finding novel and innovative treatments.
